Strategies to downregulate IL-6R on MM cells are also being explored, including metformin treatment and pharmacologic inhibition of histone deacetylase 3, both of which have been shown to decrease MM proliferation in vitro (134, 135). This evidence concerns the gene HDAC3 and Miyoshi myopathy.